Denali Therapeutics Inc
(NAS:DNLI)
$
25.69
+1.37 (+5.63%)
Market Cap: 4.11 Bil
Enterprise Value: 3.43 Bil
PE Ratio: 0
PB Ratio: 4.91
GF Score: 33/100 Denali Therapeutics Inc (DNLI) Transcripts
- 1